This could be the most valuable advice given on OrthoStreams this year.
As you know, the U.S. healthcare system has undergone a seismic shift, moving from regional hospitals where surgeons held sway to consolidated health systems governed by VACs.
For small orthopedic device companies and sales reps, getting new products or services approved is tougher than ever. Only about 5% of products submitted to VACs make the cut, and traditional tactics like pitching to surgeons no longer suffice. In a recent Bone Chat discussion (full video here), industry veteran Mark Copeland shared a battle-test...
